AV
AVTI.US Avitar Inc
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Dec 2007.
Is AVTI.US undervalued?
Graham numberThe Graham number of Avitar Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Avitar Inc fundamental analysis
No fundamental analysis for Avitar Inc yet.
Avitar Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Avitar Inc
Avitar, Inc., through its subsidiaries, designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin…
Full company profileAvitar Inc financial statements
2007 annualized: Fiscal year 2007 is not finished. Income statement and cash flow are annualized from 1 quarter up to Dec 31, 2007, the balance sheet is the latest quarter. Figures change when the annual report is published.
Avitar Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2007 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 4.08M | 6.54M | 9.62M | 4.60M | 4.05M | 4.51M | 4.52M | 3.11M | 2.02M |
| Gross Profit | 1.13M | 2.42M | 4.24M | 1.33M | 1.34M | 1.33M | 1.37M | 837K | 266K |
| Operating Income | - | - | - | - | -2.63M | -3.73M | -2.89M | -2.73M | -3.25M |
| Net Income | - | - | - | - | -2.41M | -2.43M | -3.70M | -2.26M | -5.32M |
| Balance Sheet | |||||||||
| Total Assets | 4.69M | 5.06M | 5.14M | 3.67M | 2.35M | 2.43M | 2.35M | 1.75M | 1.45M |
| Total Liabilities | 2.20M | 2.98M | 5.01M | 4.55M | 2.06M | 3.69M | 7.31M | 8.38M | 9.34M |
| Shareholders' Equity | 2.49M | 2.07M | 131K | -881K | 291K | -1.26M | -4.97M | -6.63M | -11.1M |
| Cash & Short-term Investments | 82.0K | 245K | 503K | 1.13M | 509K | 400K | 281K | 94.1K | 3.27K |
| Cash Flow | |||||||||
| Operating Cash Flow | - | - | - | - | -3.60M | -4.14M | -2.67M | -1.77M | -2.87M |
| Capital Expenditure | 192K | 147K | 144K | 9.00K | 159K | 76.5K | 140K | 21.0K | 0.00 |
| Ratios | |||||||||
| ROE | - | - | - | - | -829.8% | - | - | - | - |
| ROA | - | - | - | - | -102.7% | -100.2% | -157.8% | -129.3% | -366.3% |
| Net Profit Margin | - | - | - | - | -59.6% | -54.0% | -81.9% | -72.7% | -263.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Avitar Inc dividends
Avitar Inc has not paid dividends in the last 8 fiscal years.
Last stock split: 1:50 on Feb 21, 2006.
Who owns Avitar Inc
Ownership data of Avitar Inc is not available yet.
Avitar Inc company profile
- Company name
- Avitar Inc
- Ticker
- AVTI.US
- Exchange
- USA Stocks
- Listed since
- Aug 11, 1992
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 36
- Fiscal year end
- September
- Address
- 65 Dan Road, Canton, MA, United States, 02021
- Phone
- 781-821-2440
- Website
- -
About Avitar Inc
Avitar, Inc., through its subsidiaries, designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine, such as crack; marijuana; and methamphetamines, including meth and ecstasy. The company also provides foam disposable products, including medical-grade hydrophilic polyurethane foam disposables, such as wound dressings comprising Hydrasorb, a wound dressing product for exudating wounds; and various custom foam products comprising a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. In addition, it develops specialty wound dressings for the cardiac catheter lab market and the Illizarov Dressing used for dressing external bone fixators in orthopedic procedures. The company markets its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies, schools, and corporations through direct sales force and strategic partners, as well as through a network of distributors. Avitar, Inc. was founded in 1986 and is based in Canton, Massachusetts.
Avitar Inc management
1- Mr. Cory H. GelmonCEO, President, Treasurer & Secretary · born 1960